Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Optimal use of aromatase inhibitors: to lead or to follow?

Optimal use of aromatase inhibitors: to lead or to follow? J Clin Oncol. 2007 Jul 01; 25(19):2639-41.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.